Swipe om te navigeren naar een ander artikel
As treatment options for children with sickle cell anemia (SCA) continue to expand survival, evaluation of factors associated with health-related quality of life (HRQoL) is becoming an important aspect for further improving clinical management. Although the general features of SCA are similar, factors influencing HRQoL within a country may differ from those of other countries, therefore this study aimed to explore factors affecting HRQoL in children with SCA living in the Sultanate of Oman.
This was a cross-sectional study in which the PedsQL™ Sickle Cell Disease Module was used to evaluate the overall HRQoL in children with SCA. The socio-demographic data, clinical, and treatment outcomes were collected. Univariate and multivariate linear regression analyses were used to identify predictors of HRQoL.
A total of 123 children with SCA, aged from 2 to 16 years were enrolled. The mean total HRQoL score was 52 ± 15% (9–94), where Worry II scale recorded the highest score. The multiple regression analysis revealed that the only predictors of total HRQoL score were hemoglobin F (B = 0.64, 95% confidence interval [CI] 0.149–1.118, P = 0.009) and to a lesser degree white blood cell count (B = − 0.99, 95% CI − 1.761 to − 0.198, P = 0.01), independently of other study parameters such as age, gender, spleen status, and hydroxyurea therapy.
Collectively, these findings indicated that hemoglobin F out-weighted white blood cell count in predicting HRQoL in Omani children with SCA. Recognition of these factors could help health professionals to develop effective strategies to improve the overall HRQoL in these young patients.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Ware, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017). Sickle cell disease. The Lancet, 390(10091), 311–323.
Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., et al. (2014). Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. Journal of the American Medical Association, 312(10), 1033–1048.
Sharef, S. W., Al-Hajri, M., Beshlawi, I., Al-Shahrabally, A., Elshinawy, M., Zachariah, M., et al. (2013). Optimizing hydroxyurea use in children with sickle cell disease: Low dose regimen is effective. European Journal of Haematology, 90(6), 519–524.
Panepinto, J. A. (2012). Health-related quality of life in patients with hemoglobinopathies. Hematology. American Society of Hematology Education Program, 2012, 284–289.
Beverung, L. M., Varni, J. W., & Panepinto, J. A. (2015). Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease. Journal of Pediatric Hematology/Oncology, 37(2), 128–133.
Menezes, A. S., Len, C. A., Hilário, M. O., Terreri, M. T., & Braga, J. A. (2013). Quality of life in patients with sickle cell disease. Revista Paulista de Pediatria, 31(1), 24–29.
Panepinto, J. A., & Bonner, M. (2012). Health-related quality of life in sickle cell disease: Past, present, and future. Pediatric Blood & Cancer, 59(2), 377–385.
Badawy, S. M., Thompson, A. A., Lai, J. S., Penedo, F. J., Rychlik, K., & Liem, R. I. (2017). Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease. Pediatric Blood & Cancer, 64(6), e26369.
Thornburg, C. D., Calatroni, A., & Panepinto, J. A. (2011). Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. Journal of Pediatric Hematology/Oncology, 33(4), 251–254.
Beverung, L. M., Strouse, J. J., Hulbert, M. L., Neville, K., Liem, R. I., Inusa, B., et al. (2015). Health-related quality of life in children with sickle cell anemia: Impact of blood transfusion therapy. American Journal of Hematology, 90(2), 139–143.
Bhatia, M., Kolva, E., Cimini, L., Jin, Z., Satwani, P., Savone, M., et al. (2015). Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease. Biology of Blood and Marrow Transplantation, 21(4), 666–672.
Psihogios, A. M., Daniel, L. C., Tarazi, R., Smith-Whitley, K., Patterson, C. A., & Barakat, L. P. (2018). Family functioning, medical self-management, and health outcomes among school-aged children with sickle cell disease: A mediation model. Journal of Pediatric Psychology, 43(4), 423–433.
Panepinto, J. A., Pajewski, N. M., Foerster, L. M., Sabnis, S., & Hoffmann, R. G. (2009). Impact of family income and sickle cell disease on the health-related quality of life of children. Quality of Life Research, 18(1), 5–13.
Sehlo, M. G., & Kamfar, H. Z. (2015). Depression and quality of life in children with sickle cell disease: The effect of social support. BMC Psychiatry, 15, 78.
Barakat, L. P., Daniel, L. C., Smith, K., Renée Robinson, M., & Patterson, C. A. (2014). Parental problem-solving abilities and the association of sickle cell disease complications with health-related quality of life for school-age children. Journal of Clinical Psychology in Medical Settings, 21(1), 56–65.
McClish., D. K., Smith, W. R., Levenson, J. L., Aisiku, I. P., Roberts, J. D., Roseff, S. D., et al. (2017). Comorbidity, pain, utilization, and psychosocial outcomes in older versus younger sickle cell adults: The PiSCES project. BioMed Research International, 2017, 4070547.
Trzepacz, A. M., Vannatta, K., Gerhardt, C. A., Ramey, C., & Noll, R. B. (2004). Emotional, social, and behavioral functioning of children with sickle cell disease and comparison peers. Journal of Pediatric Hematology/Oncology., 26(10), 642–648.
Rizvi, M. A. K., & Hossain, M. Z. (2017). Relationship between religious belief and happiness: A systematic literature review. Journal of Religion and Health, 56(5), 1561–1582.
Gharaibeh, H. F., & Gharaibeh, M. K. (2012). Factors influencing health-related quality of life of thalassaemic Jordanian children. Child Care Health and Development, 38(2), 211–218.
Mevada, S. T., Al Saadoon, M., Zachariah, M., Rawas, A., Wali, A. H., Y (2016). Impact of burden of thalassemia major on health-related quality of life in Omani children. Journal of Pediatric Hematology/Oncology, 38(5), 384–388.
Dale, J. C., Cochran, C. J., Roy, L., Jernigan, E., & Buchanan, G. R. (2011). Health-related quality of life in children and adolescents with sickle cell disease. Journal of Pediatric Health Care, 25(4), 208–215.
Bhagat, V. M., Baviskar, S. R., Mudey, A. B., & Goyal, R. C. (2014). Poor health related quality of life among patients of sickle cell disease. Indian Journal of Palliative Care, 20(2), 107–111.
Brandow, A. M., Brousseau, D. C., Pajewski, N. M., & Panepinto, J. A. (2010). Vaso-occlusive painful events in sickle cell disease: Impact on child well-being. Pediatric Blood & Cancer, 54(1), 92–97.
Ingerski, L. M., Modi, A. C., Hood, K. K., Pai, A. L., Zeller, M., Piazza-Waggoner, C., et al. (2010). Health-related quality of life across pediatric chronic conditions. Journal of Pediatrics, 156(4), 639–644.
Alkindi, S., Al Zadjali, S., Al Madhani, A., Daar, S., Al Haddabi, A., Al Abri, H., et al (2010). Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin, 34(2), 135–144.
Panepinto, J. A., Paul Scott, J., Badaki-Makun, O., Darbari, D. S., Chumpitazi, C. E., Airewele, G. E., et al (2017). Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ sickle cell disease module. Health and Quality of Life Outcomes, 15(1), 124.
Thornburg, C. D., Dixon, N., Burgett, S., Mortier, N. A., Schultz, W. H., Zimmerman, S. A., et al. (2009). A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatric Blood & Cancer, 52(5), 609–615.
Steinberg, M. H., Chui, D. H., Dover, G. J., Sebastiani, P., & Alsultan, A. (2014). Fetal hemoglobin in sickle cell anemia: A glass half full? Blood, 123(4), 481–485.
Charache, S. (1997). Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Seminars in Hematology, 34(3 Suppl 3), 15–21.
Murray, N., Serjeant, B. E., & Serjeant, G. R. (1988). Sickle cell-hereditary persistence of fetal haemoglobin and its differentiation from other sickle cell syndromes. British Journal of Haematology, 69(1), 89–92.
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., et al. (1994). Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330(23), 1639–1644.
Okpala, I. (2004). The intriguing contribution of white blood cells to sickle cell disease—a red cell disorder. Blood Reviews, 18(1), 65–73.
Litos, M., Sarris, I., Bewley, S., Seed, P., Okpala, I., & Oteng-Ntim, E. (2007). White blood cell count as a predictor of the severity of sickle cell disease during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology, 133(2), 169–172.
Calia, R., Lai, C., Aceto, P., Luciani, M., Camardese, G., Lai, S., et al. (2015). Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study. Physiology & Behavior, 142, 152–154.
Calia, R., Lai, C., Aceto, P., Luciani, M., Camardese, G., Lai, S., et al. (2015). Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: Preliminary results. Renal Failure, 37(4), 678–680.
- Hemoglobin F as a predictor of health-related quality of life in children with sickle cell anemia
Rizwan Nabi Qureshi
- Springer International Publishing